10-Q: Kun Peng International Ltd. Reports Q2 2024 Results with Revenue Growth but Continued Losses

Sentiment:

Quarterly Report


Kun Peng International Ltd. saw a revenue increase in Q2 2024 compared to Q2 2023, but the company continues to operate at a loss.

Capital raiseThe company mentions that it will continue to rely on loans from directors and major shareholders and on equity sales of its common shares in order to continue to fund its business operations.The company states that issuances of additional shares will result in dilution to existing stockholders.
Worse than expectedThe company's net loss and negative working capital are worse than expected, raising concerns about its ability to continue as a going concern.The significant decrease in cash and cash equivalents is worse than expected, indicating a potential liquidity crisis.

Summary

  • Kun Peng International Ltd. reported a net loss of $597,435 for the three months ended March 31, 2024, compared to a net loss of $592,021 for the same period in 2023.
  • The company's revenue increased to $364,508 for the quarter, up from $318,951 in the prior year, driven by new revenue streams such as equipment services and technical services.
  • Operating expenses remained high at $848,683, although slightly lower than the $947,904 reported in Q2 2023.
  • For the six months ended March 31, 2024, the company's net loss was $1,131,821, compared to $1,352,334 for the same period in 2023.
  • The company's cash and cash equivalents decreased to $21,540 as of March 31, 2024, from $457,580 as of September 30, 2023.
  • The company has a negative working capital of $6,673,619 as of March 31, 2024, raising concerns about its ability to continue as a going concern.

Sentiment

Score: 3

Explanation: The document presents a mixed picture with some positive revenue growth but significant concerns about profitability, liquidity, and internal controls. The going concern warning and material weaknesses in internal controls are major red flags, leading to a low sentiment score.

Positives

  • The company experienced a 12.5% increase in revenue for the three months ended March 31, 2024, compared to the same period in 2023.
  • The launch of the Kun Zhi Jian Mini Program has diversified revenue streams.
  • Operating expenses decreased slightly for the three months ended March 31, 2024, compared to the same period in 2023.
  • The net loss for the six months ended March 31, 2024, was lower than the net loss for the same period in 2023.

Negatives

  • The company continues to operate at a loss, with a net loss of $597,435 for the three months ended March 31, 2024.
  • The company's cash and cash equivalents have decreased significantly to $21,540 as of March 31, 2024.
  • The company has a negative working capital of $6,673,619 as of March 31, 2024.
  • The company's gross profit margin decreased slightly from 77.4% to 72.7% for the three months ended March 31, 2024.

Risks

  • The company's ability to continue as a going concern is in doubt due to its negative working capital and continued losses.
  • The company relies on loans from directors and shareholders, and there is no guarantee of future financing.
  • The company faces uncertainty regarding the interpretation and enforcement of PRC laws and regulations, particularly concerning data security and VIE agreements.
  • The company's ability to transfer cash and assets out of China may be restricted by the PRC government.
  • The company has identified material weaknesses in its internal control over financial reporting.

Future Outlook

The company plans to continue exploring additional revenue streams through the Kun Zhi Jian Mini Program, leverage healthcare expertise, promote preventive health products, and offer healthcare equipment services. However, there is no assurance that these efforts will be successful or that financing will be available.

Management Comments

  • Management believes that preventive care is the most effective investment in health.
  • Management is focusing on increasing revenue through its online platform and trimming operating costs.
  • The directors intend to continue to support the group by providing adequate financial assistance to enable the group to continue its business operations for the foreseeable future.

Industry Context

The company operates in the health and wellness e-commerce sector, which has seen increased consumer interest due to global health concerns. The company's focus on preventive care aligns with current health trends. However, the company faces competition from other online retailers and healthcare providers.

Comparison to Industry Standards

  • The company's revenue growth of 12.5% for the three months ended March 31, 2024, is a positive sign, but its continued losses and negative working capital are concerning when compared to industry benchmarks.
  • Many e-commerce companies in the health and wellness sector are focused on profitability and sustainable growth, which Kun Peng International is still struggling to achieve.
  • The company's reliance on related-party loans and the lack of a functioning audit committee are not in line with best practices for publicly traded companies.
  • Compared to companies like JD Health or Alibaba Health, which have established market positions and strong financial backing, Kun Peng International is still in an early stage of development and faces significant challenges.

Related Party Transactions

  • The company has significant amounts due to related parties, including Ms. Chengyuan Li, Ms. Jinjing Zhang, and Ms. Xiujin Wang, for operational support and working capital requirements.
  • These payables are interest-free, unsecured, and repayable on demand.

Stakeholder Impact

  • Shareholders face the risk of further dilution due to potential equity sales.
  • Employees may be impacted by the company's financial instability.
  • Customers may be affected by the company's ability to fulfill orders and provide services.
  • Suppliers and creditors face the risk of non-payment due to the company's liquidity issues.

Next Steps

  • The company will continue to explore additional revenue streams through the Kun Zhi Jian Mini Program.
  • The company will leverage healthcare expertise and technology with local healthcare service providers.
  • The company will promote and sell preventive healthcare dietary supplements and products.
  • The company will offer healthcare equipment services at the Kun Zhi Jian Customer Service Center.
  • The company plans to hire additional personnel in financial reporting and accounting and provide training to newly hired personnel.
  • The company plans to hire an experienced controller and build an internal accounting team with sufficient in-house expertise in U.S. GAAP reporting once its cash position improves.

Key Dates

DateDescription
2017-06-28Kun Peng International Limited incorporated.
2017-08-11Kunpeng (China) Industrial Development Company Limited incorporated.
2019-03-20King Eagle (China) Co., Ltd. incorporated.
2020-09-02King Eagle (Tianjin) Technology Co., Ltd. incorporated.
2021-04-20Kun Peng International Holding Limited incorporated.
2021-05-14SAFE registration effected for King Eagle (Tianjin) shareholders.
2021-06-21Kun Peng (Hong Kong) Industrial Development Limited incorporated.
2021-08-10Kun Peng Tian Yu Health Technology (Tianjin) Co., Ltd. incorporated.
2022-10-12Authorized common stock increased to 1,000,000,000 shares.
2022-10-1810:1 forward stock split effected.
2022-11-08Company name changed to Kun Peng International Ltd.
2022-12-01King Eagle (Beijing) Technology Co., Ltd. incorporated.
2023-03-03Ownership transfer of King Eagle (China) completed.
2023-09-19King Eagle (Huaian) Health Management Co., Ltd. incorporated.
2023-10-26Kun Zhi Jian (Huaian) Technology Co., Ltd. incorporated.
2023-11-23Kun Pin Hui (Shandong) Trading Co., Ltd. incorporated.
2024-01-30Kun Zhi Jian (Shandong) Health Management Co., Ltd incorporated.
2024-02-01Chengdu Wenjiang Pengrun Internet Healthcare Co., Ltd incorporated.
2024-02-02Deregistration of Kunpeng (China) Industrial Development Company Limited approved.
2024-03-31End of the reporting period for the quarterly report.
2024-04-10King Eagle (Tianjin) acquired Kun Pin Hui (Shandong) Trading Co., Ltd.
2024-05-14Date of the report, with 400,000,000 shares of common stock issued and outstanding.
2024-05-15Date of the report signatures.

Keywords

e-commerce, healthcare, preventive care, online platform, financial results, China, VIE, Kun Peng International, King Eagle Mall, Kun Zhi Jian

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.